ASPSCR1 and alveolar soft part sarcoma: The ASPL/ASPSCR1-TFE3 fusion type is associated with unfavorable outcomes [7] and shares the same chromosomal breakpoint as alveolar soft part sarcoma, which is refractory to chemotherapy [11].